1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Vascular Solutions

Anonymous board for Vascular Solutions


Sort By:
Title
Replies Views
Last Message ↑
  1. Anonymous
    Replies:
    3
    Views:
    6,544
  2. Anonymous
    Replies:
    12
    Views:
    10,630
  3. Anonymous
    Replies:
    0
    Views:
    4,086
  4. Anonymous
    Replies:
    1
    Views:
    3,991
  5. Anonymous
    Replies:
    4
    Views:
    5,307
  6. anonymous
    Replies:
    0
    Views:
    1,917
  7. anonymous
    Replies:
    0
    Views:
    2,390

Thread Display Options

Loading...